Skip to main content

Table 1 Diagnostic findings in patients with WD (n = 1366)

From: Clinical and genetic characterization of a large cohort of patients with Wilson’s disease in China

 

Hepatic (n = 307)

Neurologic (n = 737)

Asymptomatic (n = 238)

Others (n = 20)

Siblings (n = 64)

Males (%)

173 (56.4)

437 (59.3)

161 (67.6)

12 (60.0)

38 (59.4)

Age at onset (years)

 Range

2.6–64.8

5.5–62.6

1.8–50.9

4.7–26.0

-

 Mean ± SD

17.6 ± 10.4

19.3 ± 8.0

9.5 ± 8.0

12.0 ± 5.5

-

Age at diagnosis (years)

 Range

3.1–65.6

5.5–62.8

2.0–54.2

5.3–26.8

2.8–48.0

 Mean ± SD

18.5 ± 10.8

20.2 ± 8.4

10.4 ± 8.7

13.2 ± 5.1

13.8 ± 10.9

Presented symptoms (male/female)

Acute hepatic WD (39/35)

Chronic hepatic WD (134/99)

Dystonia (289/193)

Tremor (325/200)

Gait abnormality (204/153)

Dysarthria (298/228)

Swallowing difficulty (88/55)

Salivation (166/125)

Elevated transaminases (160/73)

K–F rings (1/4)

Osseomuscular (8/7)

Renal (4/1)

Asymptomatic (29/24)

Hepatic (3/0)

Neurologic (5/2)

Renal (1/0)

CPL < 0.1 g/l (%)

275/303 (90.8)

698/728 (95.9)

208/227 (91.6)

19/20 (95.0)

58/60 (96.7)

K–F ring (%)

273 (88.9)

708 (96.1)

117 (49.2)

17/3 (85.0)

36 (56.3)

  1. SD standard deviation, CPL ceruloplasmin level, K–F rings Kayser–Fleischer rings